 |
|
High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology
Tae-Wook Kong, Miseon Kim, Young-Han Kim, Yong Beom Kim, Jayeon Kim, Jae-Weon Kim, Mi Hye Park, Joo Hyun Park, Jeong Ho Rhee, Myong Cheol Lim, Joon-Seok Hong,
Obstet Gynecol Sci. 2020;63(2):107-107. Published online 2020 Feb 18 DOI: https://doi.org/10.5468/ogs.2020.63.2.107
|
|
Citations to this article as recorded by
 Targeted Next Generation Sequencing for Human Papillomavirus Genotyping in Cervical Liquid-Based Cytology Samples
Karoline Andersen, Kasper Holm, Mette Tranberg, Cecilie Lebech Pedersen, Sara Bønløkke, Torben Steiniche, Berit Andersen, Magnus Stougaard
Cancers.2022; 14(3): 652. CrossRef Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesion cytology, and its immediate risk for high-grade cervical lesion or cancer: a single-center, cross-sectional study
Nida Jareemit, Navin Horthongkham, Suwanit Therasakvichya, Boonlert Viriyapak, Perapong Inthasorn, Mongkol Benjapibal, Vuthinun Achariyapota, Irene Ruengkhachorn
Obstetrics & Gynecology Science.2022; 65(4): 335. CrossRef
|